biolinerx
BioLineRx, CTTQ To Commercialize Hepatitis C Drug, BL-8030, In China
BioLineRx has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharma to commercialize BL-8030 in China.
BioLineRx has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharma to commercialize BL-8030 in China.